Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 3:58 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 49–72 of 245 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Mineralization Clear all

Conditions: Osteopenia
Interventions: Low magnitude mechanical stimulation, Sham low magnitude mechanical stimulation; Device
Lead sponsor: Hebrew SeniorLife; Other
Eligibility: 60 Years and older
Enrollment: 174 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Rheumatoid Arthritis
Interventions: Not listed
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older
Enrollment: 1,745 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Mild Autonomous Cortisol Secretion (MACS)
Interventions: Osilodrostat (Isturisa); Drug
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Osteopenia
Interventions: AlgaeCal-1, AlgaeCal-2; Dietary Supplement
Lead sponsor: Integrative Health Technologies, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 354 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Ulcerative Colitis, Crohn's Disease
Interventions: Calcitonin nasal spray (salmon); Drug
Lead sponsor: Boston Children's Hospital; Other
Eligibility: 8 Years to 22 Years
Enrollment: 66 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Renal Osteodystrophy, Chronic Kidney Diseases, CKD-MBD, Bone Turnover Rate Disorder, Secondary Hyperparathyroidism
Interventions: miRNAseq analysis, Standard treatment for bone disorder; Procedure · Drug
Lead sponsor: Thomas Nickolas; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Osteoporosis
Interventions: Alendronate; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 5 Years to 15 Years
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2009
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Hyperphosphatemia
Interventions: Niacinamide, Placebo; Drug
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older
Enrollment: 17 participants
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Post Menopausal Osteoporosis
Interventions: ibandronate [Bonviva/Boniva]; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 55 Years to 80 Years · Female only
Enrollment: 1,395 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 19
States / cities: Little Rock, Arkansas • Irvine, California • Rancho Mirage, California + 16 more

Conditions: Barrett's Esophagus, Erosive Esophagitis, Gastroesophageal Reflux Disease(GERD)
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 40 Years to 75 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Vitamin D Deficiency, Obesity
Interventions: Not listed
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 3 Years to 12 Years
Enrollment: 45 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Metabolic Bone Disease, Osteopenia, Neonatal Rickets
Interventions: Vibro-acoustic analysis (VAA), based on ultrasound radiation force; Diagnostic Test
Lead sponsor: Mayo Clinic; Other
Eligibility: 3 Days to 8 Months
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Type 1 Diabetes, Osteoporosis
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 6 Years to 20 Years
Enrollment: 242 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2024
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Phosphorus and Calcium Disorders, Chronic Kidney Disease Mineral and Bone Disorder, Chronic Kidney Diseases
Interventions: High Phosphorus Diet, Low Phosphorus Diet; Other
Lead sponsor: University of Minnesota; Other
Eligibility: 30 Years to 75 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Breast Cancer, Osteoporosis
Interventions: biologic sample preservation procedure, dual x-ray absorptometry; Other · Procedure
Lead sponsor: NCIC Clinical Trials Group; Network
Eligibility: 35 Years and older · Female only
Enrollment: 238 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2013
U.S. locations: 13
States / cities: Torrance, California • Washington D.C., District of Columbia • Scarborough, Maine + 9 more

Conditions: Diabetes Mellitus, Type 2
Interventions: Rosiglitazone, Metformin; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 55 Years to 80 Years · Female only
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 21
States / cities: Tucson, Arizona • Huntington Park, California • Los Angeles, California + 15 more

Conditions: Osteopenia, Renal Osteodystrophy
Interventions: pamidronate; Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2007
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Anorexia Nervosa, Hypothalamic Amenorrhea, Obesity
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 61 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2009
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Vitamin D Deficiency, Osteoporosis, Osteopenia
Interventions: Calcium 500mg with 200 IU Vitamin D - 2 tablets daily, Blood levels of Vitamin D, Serum CTX, Mg, Ca++ and iPTH, Usual sun exposure documentation, Dietary intake of calcium, vitamin D, magnesium; Drug · Procedure · Behavioral
Lead sponsor: McLennan County Medical Education and Research Foundation; Other
Eligibility: 70 Years and older · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Waco, Texas

Conditions: Kidney Failure, Chronic, Chronic Kidney Disease-Mineral and Bone Disorder
Interventions: Oral calcitriol with cinacalcet rescue, IV activated vitamin D; Drug
Lead sponsor: University of Washington; Other
Eligibility: 18 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Prostate Cancer, Osteoporosis, Hypogonadism
Interventions: alendronate; Drug
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 50 Years to 85 Years · Male only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Osteoporosis, Renal Osteodystrophy, Kidney Transplant; Complications
Interventions: Denosumab Inj 60 mg/ml, Placebo; Drug · Other
Lead sponsor: Thomas Nickolas, MD MS; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 3
States / cities: Chicago, Illinois • Evanston, Illinois • New York, New York

Conditions: Effect of Treatment on Bone Mineral Density
Interventions: enclomiphene citrate, Placebo; Drug
Lead sponsor: Repros Therapeutics Inc.; Industry
Eligibility: 18 Years to 60 Years · Male only
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 17
States / cities: Mesa, Arizona • Phoenix, Arizona • Tempe, Arizona + 14 more

Conditions: Osteoporosis
Interventions: Lagenbone; Dietary Supplement
Lead sponsor: Southern California University of Health Sciences; Other
Eligibility: 40 Years to 80 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Whittier, California

Search by objective public record fields.

"VIBES"--Low Magnitude Mechanical Stimulation to Improve Bone Mineral Density

Rheumatoid Arthritis Comorbidity: Bone Health in Men and African Americans

Isturisa Treatment in Mild Autonomous Cortisol Secretion( MACS)

A Comparison of Changes in Bone Density With the Same Bone-health Plan, But With Different Bone-health Supplements

Nasal Calcitonin in the Treatment of Bone Mineral Loss in Children and Adolescents With Inflammatory Bowel Disease

Precision Medicine Approaches to Renal Osteodystrophy

Safety and Efficacy of Alendronate (Fosamax) in Children With Osteoporosis

The Effect of Oral Niacinamide on Plasma Phosphorus Levels in Peritoneal Dialysis Patients

DIVA Study - A Study of Different Regimens of Intravenous Administration of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis

To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use

Vitamin D Deficiency and Low Bone Mineral Content in Children

A Study to Assess Metabolic Bone Disease of Prematurity Using an Acoustic Method

Bone Health in Youth With Type 1 Diabetes

Calcium and Phosphorus Whole-Body Balance and Kinetics in Patients With Moderate Chronic Kidney Disease

Bone Mineral Density in Postmenopausal Women at Increased Risk of Breast Cancer And Who Are Receiving Exemestane on MAP3

Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health

Osteopenia and Renal Osteodystrophy: Evaluation and Management

Hormone Dynamics and Bone Mineral Density in Anorexia Nervosa v. Hypothalamic Amenorrhea

Vitamin D Deficiency in Elderly African American Women in Central Texas

DePTH: De-emphasize PTH

Prevention of Osteoporosis in Men With Prostate Cancer

The Effects of 12-months of Denosumab on Bone Density in Prevalent Kidney Transplant Recipients

Assessment of the Effects of Enclomiphene Citrate on Bone Mineral Density in Men With Secondary Hypogonadism

Effects of Lagenbone on Bone Mineral Density